Clinical trial
The Effect of Liraglutide as an Adjunct to Dietary Intervention on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes
NCT07913685 is registered in ClinicalTrials.gov with Medical University of Bialystok as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Liraglutide as an Adjunct to Dietary Intervention on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes
- Lead sponsor
- Medical University of Bialystok
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 5, 2023
- Completion date
- January 19, 2026
- Enrollment
- 83 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obesity & overweight
Arms
As registered; 2 arms.
-
Liraglutide+low-calorie diet
Liraglutide administered once daily s.c. + low-calorie diet Duration: 12 weeks
-
Low-calorie diet
Low-calorie diet Duration: 12 weeks
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Change in body weight (kg)
Observed change in body weight from baseline to week 12 in the group treated with liraglutide+LCD compared to dietary intervention alone.
Lead sponsor's other trials
Medical University of Bialystok, most recent start first.
+66 more trials See the organization page
Similar trials
Same condition (Weight Loss) and phase, most recent start first.
+76 more trials See the condition page